Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,158 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05367245RecruitingPhase 2
Butyrate supplement for Gulf War illness symptoms
This study tests whether a daily supplement called calcium-magnesium butyrate can reduce symptoms like fatigue, pain, and digestive issues in veterans with Gulf War illness. Butyrate is a substance that may help the gut and immune system work better.
Long Beach, CaliforniaAges 40–70 - NCT07789106Recruiting
Coenzyme Q10 study for tiredness and strength while on weight-loss injections
This study tests whether a supplement called ubiquinol (a form of coenzyme Q10) can reduce tiredness and help maintain muscle strength in people who are starting weight-loss injections like Wegovy or Mounjaro. If you qualify, you might receive the supplement or a placebo to see how it affects your energy and strength.
GlasgowAges 30–65 - NCT07880041Recruiting
Hair supplement study for women ages 45 to 60
This study tests a dietary supplement designed to improve hair growth and quality in women who are going through menopause or have irregular periods. It may help if you are noticing thinning hair.
NiceAges 45–60 - NCT07881224RecruitingPhase 1
Fosmanogepix interaction and heart safety in healthy people
This early study checks how fosmanogepix, a medicine being tested, interacts with other drugs and whether it affects the heart's rhythm. It is for healthy adults to see how the body handles the drug and confirm it is safe before larger studies.
Groningen, NetherlandsAges 18–55 - NCT07048262RecruitingPhase 2
Inhaled study treatment for adults with non-CF bronchiectasis
This study tests a new inhaled medicine (called CSL787) for people with bronchiectasis that is not caused by cystic fibrosis. It aims to see if the medicine can reduce chest infections and improve symptoms. You will receive the treatment as a mist you breathe in, and the study lasts for about a year.
QueenslandAges 18–85 - NCT04971954Recruiting
Nicotine test to improve age-related hearing processing
This study tests whether nicotine can improve how your brain processes sounds, which can get worse with age. It’s designed for non-smokers without significant hearing or medical/medication issues.
Irvine, CaliforniaAges 18–85 - NCT06956014RecruitingPhase 3
Testing a new drug for chronic back and leg pain
This trial tests an investigational drug called VER-01 for people with long-term pain from a pinched nerve in the lower back. It aims to see if the drug safely reduces pain and improves daily life.
Mobile, AlabamaAges 18 years+ - NCT05212246RecruitingPhase 3
Imiquimod cream to prevent basal cell carcinoma in veterans
This study tests whether applying imiquimod cream (a common skin treatment) to the face can prevent new basal cell carcinomas from forming in people who have already had several. It is designed for Veterans at high risk for this type of skin cancer.
Long Beach, CaliforniaAges 18 years+ - NCT07607587RecruitingPhase 1
Testing a new weight-loss drug for people who couldn't tolerate GLP-1 shots
This study tests a new injectable medication called cagrilintide for people with obesity who had to stop GLP-1 drugs (like Ozempic or Wegovy) because of stomach problems. The goal is to see if cagrilintide causes fewer stomach side effects while still helping with weight.
Walnut Creek, CaliforniaAges 18 years+ - NCT07855211RecruitingPhase 1/Phase 2
Safety study of BIIB147 for adults with ALS
This study tests a new medicine called BIIB147 to see if it is safe and to learn how it affects people with ALS. It may help slow the progression of the disease.
St Louis, MissouriAges 18 years+ - NCT06159673RecruitingPhase 2/Phase 3
ACP-204 for Alzheimer's with psychosis
This study tests a new medicine called ACP-204 for people with Alzheimer's disease who also have psychosis (like seeing or hearing things that aren't real). It aims to see if the drug can help reduce these symptoms safely.
Chandler, ArizonaAges 55–95 - NCT07536061RecruitingPhase 1
Testing SRP-1005 in early-stage Huntington's disease
This first-in-human study tests whether SRP-1005, a new drug, is safe and tolerable in people with early Huntington's disease. The drug is designed to reduce levels of a harmful protein in the brain that causes Huntington's symptoms.
Westmead, New South WalesAges 21–70 - NCT07610837RecruitingPhase 2
Testing AZD2389 for fatty liver disease with scarring
This study tests whether a new drug called AZD2389 is safe and well-tolerated in adults with steatotic liver disease (fatty liver) that has progressed to advanced scarring. The trial aims to see if this drug might help slow or improve liver damage in people with this condition.
Chandler, ArizonaAges 18 years+ - NCT07112456RecruitingPhase 2
Nebulized ketamine for moderate to severe asthma attacks
This study tests whether adding a nebulized medication called ketamine to standard asthma treatment helps people having a moderate to severe asthma attack breathe better. Ketamine is usually used as an anesthetic, but in this form it may help relax the airways.
Muscat, AlkhoudhAges 18 years+ - NCT07809945RecruitingPhase 1
Weight loss study for people with overweight or obesity
This study tests a new medication called IBI3046 for people who are overweight or have obesity. The purpose is to see if it helps with weight loss and works safely.
Beijing, Beijing MunicipalityAges 18–65 - NCT07810010RecruitingPhase 2
Vaccine for RSV and HMPV in adults 60 and older
This study tests a new vaccine that protects against two common respiratory viruses: RSV and HMPV. It aims to see if the vaccine is safe and works well in older adults, who are at higher risk for serious illness from these viruses.
Bruse, Australian Capital TerritoryAges 60 years+ - NCT07357727RecruitingPhase 3
Study of Pelabresib and Ruxolitinib for Myelofibrosis
This trial tests a combination of two drugs (pelabresib and ruxolitinib) for people with myelofibrosis whose spleen is enlarged and who have bothersome symptoms. It aims to see if adding pelabresib to standard care helps control the disease better.
Denver, ColoradoAges 18 years+ - NCT07404865RecruitingPhase 3
Telitacicept for active primary Sjögren's disease
This study tests an investigational drug called telitacicept for people with active primary Sjögren's disease. The goal is to see if it can reduce symptoms like joint pain, fatigue, and swelling better than a placebo.
Chandler, ArizonaAges 18–75 - NCT06500702RecruitingPhase 2
Study of three drugs for FSGS or minimal change disease
This study tests three experimental drugs (frexalimab, brivekimig, and rilzabrutinib) for people ages 16 to 75 with a type of kidney disease called primary FSGS or minimal change disease. The goal is to see if these drugs can reduce protein in your urine and help protect your kidneys.
Birmingham, AlabamaAges 16–75 - NCT07098988RecruitingPhase 2
Visugromab plus standard chemo-immunotherapy for lung cancer
This trial tests an experimental drug called visugromab added to standard chemotherapy and immunotherapy for people newly diagnosed with advanced non-squamous lung cancer. It aims to see if the combination works better than standard treatment alone.
Birmingham, AlabamaAges 18 years+ - NCT07752823Recruiting
A prebiotic supplement for mild to moderate anxiety in adults
This study tests whether a special food ingredient (a prebiotic) can help ease anxiety in adults. You'll take a daily supplement for a few months and answer questions about your symptoms from home.
Del Mar, CaliforniaAges 21–80 - NCT06274749Recruiting
Urolithin A for blood sugar in adults 55+ with extra weight
This study tests if a natural supplement called Urolithin A can help improve how your body handles sugar (glucose) in healthy adults aged 55 and older who have a higher body weight. You would take a daily capsule and come in for tests including blood work, treadmill walks, and an MRI.
Baltimore, MarylandAges 55–100 - NCT07386249Recruiting
Wheat lipid cream for vaginal dryness in postmenopausal women
This trial tests a cream made from wheat polar lipids to see if it helps with vaginal dryness after menopause. It may offer a non-hormonal option for women with moderate to severe discomfort.
Louvain-la-Neuve, BelgiumAges 45–65 - NCT07527650RecruitingPhase 2
Testing HM15275 for Type 2 Diabetes Management
This study tests a new medication called HM15275 to help control blood sugar in people with type 2 diabetes. The trial will check if the medication works well and is safe when added to diet, exercise, or metformin treatment.
Mesa, ArizonaAges 18–75
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,158 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.